Representative before the EPO

Company dna sagittarius ip
no operation time available
1 office
active in Legal Services

We have observed 6 EP applications Jessica Ann Kershaw has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12806092

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

IPC classification:
A61K 31/4178, A61K 31/4439, A61K 31/506, A61P 25/08, A61P 25/18, A61P 27/16, A61P 43/00, C07D 307/52, C07D 307/79, C07D 405/12, C07D 405/14
Agent:
Multiple attorneys, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13725443

HYDANTOIN DERIVATIVES AS KV3 INHIBITORS

IPC classification:
A61K 31/4166, A61K 31/4439, A61K 31/506, A61P 25/00, C07D 307/87, C07D 307/94, C07D 311/76, C07D 401/04, C07D 403/04, C07D 405/12, C07D 405/14
Agent:
Multiple attorneys, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13725447

TRIAZOLES AS KV3 INHIBITORS

IPC classification:
A61K 31/4196, A61P 25/00, C07D 249/12, C07D 401/04, C07D 405/14
Agent:
Multiple attorneys, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13845830

METHOD OF TREATING IRON DEFICIENCY ANEMIA

IPC classification:
A61K 33/26, G01N 33/00, G01N 33/53
Agent:
Jessica Ann Kershaw, Sagittarius IP
Agent:
Patent Boutique LLP
Status:
GRANT OF PATENT INTENDED
EP14702592

COATING FOR SUBSTRATE

IPC classification:
A61L 27/34, A61L 29/08, A61L 31/10
Applicant:
W.L. Gore & Associates Inc
Agent:
Multiple attorneys, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14757932

NOVEL DRUG FORMULATION

IPC classification:
A61K 9/00, A61K 9/107, A61K 31/166, A61K 45/06, A61K 47/26, A61K 47/32, A61P 31/04
Agent:
Multiple attorneys, Sagittarius IP
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature